Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REVIVE-CVST: Endovascular Thrombectomy in Severe Cerebral Venous Sinus Thrombosis
NCT07548346Recruiting
- Sponsor
- MENASINO
- Start
- Jan 2025
- Primary completion
- Jan 2029
- Countries
- 8
01
Overview
Randomised, single-blind trial in cerebral venous sinus thrombosis (CVST) (2 arms), sponsored by MENASINO. Primary endpoint: Proportion of patients achieving functional independence (mRS 0-2) at 12 months. Started Jan 2025; status: recruiting.
02
Conditions
cerebral venous sinus thrombosis (CVST)
Beyond the preview
Go deeper on NCT07548346.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07548346.